Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Pancreas ; 41(4): 596-604, 2012 May.
Article in English | MEDLINE | ID: mdl-22158076

ABSTRACT

OBJECTIVES: The immunosuppressant tacrolimus (FK506) has improved pancreas allograft survival compared with cyclosporin A (CsA), possibly because of reduced acute pancreatitis following ischemia-reperfusion injury. Ion permeabilities in zymogen granule (ZG) membranes, including a KCNQ1 K channel, promote hormone-stimulated enzyme secretion. We investigated whether a differential modulation of ZG and lysosomal ion permeabilities and enzyme secretion by CsA/FK506 contributes to pancreatitis. METHODS: Rat ZGs and lysosomes were isolated by gradient centrifugation, ion permeabilities assayed by osmotic lysis, and single-channel currents recorded in a planar lipid bilayer. Amylase release was measured in permeabilized acini and lysosomal cathepsin B release detected by immunoblotting. RESULTS: CsA (1-10 µM), but not FK506, enhanced ZGs osmotic lysis by selectively increasing K permeability up to 5-fold. Zymogen granule membrane K channels showed ∼2-fold increased single-channel open probability with CsA only. Cyclosporin A selectively increased basal (∼2-fold), but not cholecystokinin-octapeptide (1 nM)-induced amylase secretion in K medium only. Cyclosporin A (5 µM), but not FK506, increased cathepsin B release from lysosomes. CONCLUSIONS: Cyclosporin A selectively opens the ZG K channel and induces cathepsin B release from lysosomes, which cause increased in situ lysis of ZGs and may aggravate or fuel acute allograft pancreatitis following hypoxia-reperfusion injury.


Subject(s)
Cyclosporine/adverse effects , Immunosuppressive Agents/pharmacology , Lysosomes/drug effects , Pancreas/drug effects , Potassium Channels/drug effects , Secretory Vesicles/drug effects , Tacrolimus/pharmacology , Acinar Cells/drug effects , Acinar Cells/metabolism , Amylases/metabolism , Animals , Biomarkers/metabolism , Cathepsin B/metabolism , Immunosuppressive Agents/adverse effects , Lysosomes/metabolism , Male , Osmosis/drug effects , Pancreas/blood supply , Pancreas Transplantation , Pancreatitis, Graft/etiology , Permeability/drug effects , Potassium Channels/metabolism , Rats , Rats, Wistar , Reperfusion Injury/etiology , Secretory Vesicles/metabolism
2.
Cell Physiol Biochem ; 22(5-6): 567-78, 2008.
Article in English | MEDLINE | ID: mdl-19088439

ABSTRACT

The phytostilbene resveratrol (RV) improves the metabolic state in animal models by increasing the insulin responsiveness of tissues and there is evidence that RV affects insulin secretion from native beta-cells and insulinoma cells. In whole cell patch clamp experiments on clonal rat INS-1E cells we used high extracellular glucose (20 mM), extracellular hypotonicity (30%) or tolbutamide (100 microM) to elicit membrane depolarizations and electrical activity. Application of RV (50 microM) repolarized the cells, terminated electrical activity and prevented the hypotonicity-induced depolarization. These effects were fully reversible and intermittent application of RV restored tolbutamide-induced electrical activity after desensitization. Glucose-induced depolarization was counteracted by RV in presence of iberiotoxin (50 nM), showing that the RV effect does not depend on BK(Ca) channel activation. RV dose-dependently inhibited K(ATP) currents, L- and T-type Ca(2+) currents and swelling-dependent Cl(-) currents evoked by either hypotonicity or high extracellular glucose--ion conductances crucially involved in regulating the electrical activity of insulin secreting cells. We further show that RV blunts glucose-induced, but not basal insulin release. Our results indicate that RV counteracts/prevents stimulus-induced cell membrane depolarization and electrical activity by blocking voltage-gated Ca(2+)- and swelling-dependent Cl(-) currents despite the inhibition of K(ATP) currents.


Subject(s)
Calcium Channels/metabolism , Chloride Channels/metabolism , Insulin/metabolism , Insulinoma/metabolism , Ion Channel Gating/drug effects , Stilbenes/pharmacology , Animals , Glucose/pharmacology , Insulin Secretion , Nifedipine/pharmacology , Patch-Clamp Techniques , Peptides/pharmacology , Rats , Resveratrol , Solutions , Tolbutamide/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...